{
    "title": "British drugmaker Indivior weighs U.S. listing, annual sales rise",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10518437/British-drugmaker-Indivior-weighs-U-S-listing-annual-sales-rise.html",
    "date": "2022-02-16",
    "keywords": [
        "growth",
        "aripaka",
        "addiction",
        "indivior",
        "listing",
        "sublocade",
        "treatment",
        "maker",
        "market",
        "company",
        "rise",
        "newer",
        "therapy",
        "boost",
        "reckitt",
        "competition",
        "drawnout",
        "drug",
        "view",
        "profile",
        "visibility",
        "chief",
        "executive",
        "mark",
        "crossley",
        "statement",
        "httpswwwrnspdflondonstockexchangecomrns7960b_12022215pdf",
        "topic",
        "board",
        "management",
        "intend",
        "path",
        "trade",
        "opioid",
        "crisis",
        "disease",
        "control",
        "prevention",
        "country",
        "spread",
        "omicron",
        "variant",
        "coronavirus",
        "healthcare",
        "staff",
        "forecast",
        "expectation",
        "drugmaker",
        "year",
        "operating",
        "profit",
        "loss",
        "track",
        "reporting",
        "pushkala",
        "bengaluru",
        "editing",
        "rashmi",
        "aich",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}